Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 285 participants.

Also called NCT01765452

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 285 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01765452
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01765452. Randomized; no masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2013-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone
Intervention (Drug)
Closone
Intervention (Drug)
Plavix with Astrix
Lead sponsor
HK inno.N Corporation (class: industry)

Record details

Record id
cardio:ct-nct01765452
Content hash
8a1265442d8cac632eaa634fdc4913e3c3c072d312b0a0fe67abd83be8f8649a